Hypermethylation of Adenomatosis Polyposis Coli-2 and its Tumor Suppressor Role in Retinoblastoma

References

• Chintagumpala M, Chevez-Barrios P, Paysse EA, Plon SE, Hurwitz R. Retinoblastoma: review of current management. Oncologist 2007;12:1237–1246
   PubMed Web of Science ®Google Scholar
• Rius M, Lyko F. Epigenetic cancer therapy: rationales, targets and drugs. Oncogene 2012;31:4257–4265
   PubMed Web of Science ®Google Scholar
• Dawson MA, Kouzarides T. Cancer epigenetics: from mechanism to therapy. Cell 2012;150:12–27
   PubMed Web of Science ®Google Scholar
• Zhang J, Benavente CA, McEvoy J, Flores-Otero J, Ding L, Chen X, et al. A novel retinoblastoma therapy from genomic and epigenetic analyses. Cancer Res 2000;60:366–371
   Google Scholar
• Chau KY, Manfioletti G, Cheung-Chau KW, Fusco A, Dhomen N, Sowden JC, et al. Derepression of hmga2 gene expression in retinoblastoma is associated with cell proliferation. Mol Med 2003;9:154–165
   Google Scholar
• Bai SW, Li B, Zhang H, Jonas JB, Zhao BW, Shen L, et al. Pax6 regulates proliferation and apoptosis of human retinoblastoma cells. Invest Ophthalmol Vis Sci 2011;52:4560–4570
   PubMed Web of Science ®Google Scholar
• Mitra M, Kandalam M, Verma RS, Maheswari UK, Kumar KS. Genome-wide changes accompanying the knockdown of Ep-CAM in retinoblastoma. Mol Vis 2010;16:828–842
   PubMed Web of Science ®Google Scholar
• Ohtani-Fujita N, Dryja TP, Rapaport JM, Fujita T, Matsumura S, Ozasa K. Hypermethylation in the retinoblastoma gene is associated with unilateral, sporadic retinoblastoma. J Cell Physiol 2010;223:143–150
   Google Scholar
• Ohtani-Fujita N, Fujita T, Aoike A, Osifchin NE, Robbins PD, Sakai T. CpG methylation inactivates the promoter activity of the human retinoblastoma tumor-suppressor gene. Cancer Genet Cytogenet 1997;98:43–49
   PubMed Web of Science ®Google Scholar
• Stirzaker C, Millar DS, Paul CL, Warnecke PM, Harrison J, Vincent PC, et al. Extensive DNA methylation spanning the Rb promoter in retinoblastoma tumors. Cancer Res 1997;57:2229–2237
   PubMed Web of Science ®Google Scholar
• Indovina P, Acquaviva A, De Falco G, Rizzo V, Onnis A, Luzzi A, et al. Downregulation and aberrant promoter methylation of p16INK4A: a possible novel heritable susceptibility marker to retinoblastoma. J Cell Physiol 2009;223:143–150
   Google Scholar
• Cohen Y, Merhavi-Shoham E, Avraham RB, Frenkel S, Pe'er J, Goldenberg-Cohen N. Hypermethylation of CpG island loci of multiple tumor suppressor genes in retinoblastoma. Exp Eye Res 2008;86:201–206
   PubMed Web of Science ®Google Scholar
• Robertson KD. DNA methylation, methyltransferases, and cancer. Oncogene 2001;20:3139–3155
   PubMed Web of Science ®Google Scholar
• Nan X, Ng HH, Johnson CA, Laherty CD, Turner BM, Eisenman RN, et al. Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature. 1998;393:386–389
   PubMed Web of Science ®Google Scholar
• Jones PL, Veenstra GJ, Wade PA, Vermaak D, Kass SU, Landsberger N, et al. Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription. Nat Genet 1998;19:187–191
   PubMed Web of Science ®Google Scholar
• Jonkers J, Meuwissen R, van der Gulden H, Peterse H, van der Valk M, Berns A. Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer. Nat genet 2001;29:418–425
   PubMed Web of Science ®Google Scholar
• Jin Z, Tamura G, Tsuchiya T, Sakata K, Kashiwaba M, Osakabe M, et al. Adenomatous polyposis coli (APC) gene promoter hypermethylation in primary breast cancers. Nature 2012;481:329–334
   Google Scholar
• Merlo A, Herman JG, Mao L, Lee DJ, Gabrielson E, Burger PC, et al. 5′ CpG island methylation is associated with transcriptional silencing of the tumor suppressor p16/CDKN2/MTS1 in human cancers. Nat Med 1995;1:686–692
   PubMed Web of Science ®Google Scholar
• Dobrovic A, Simpfendorfer D. Methylation of the BRCA1 gene in sporadic breast cancer. Cancer Res 1997;57:3347–3350
   PubMed Web of Science ®Google Scholar
• Oki Y, Issa JP. Review: recent clinical trials in epigenetic therapy. Rev Recent Clin Trials 2006;1:169–182
   PubMedGoogle Scholar
• Yeo W, Chung HC, Chan SL, Wang LZ, Lim R, Picus J, et al. Epigenetic therapy using belinostat for patients with unresectable hepatocellular carcinoma: a multicenter phase I/II study with biomarker and pharmacokinetic analysis of tumors from patients in the Mayo Phase II Consortium and the Cancer Therapeutics Research Group. J ClinOncol 2012;30:3361–3367
   PubMed Web of Science ®Google Scholar
• Esteller M, Sparks A, Toyota M, Sanchez-Cespedes M, Capella G, Peinado MA, et al. Analysis of adenomatous polyposis coli promoter hypermethylation in human cancer. Cancer Res 2000;60:4366–4371
   PubMed Web of Science ®Google Scholar
• Van Es J, Kirkpatrick M, Vande WM, Molenaar M, Miles A, Kuipers J, et al. Identification of APC2, a homologue of the adenomatous polyposis coli tumor suppressor. Curr Biol 1999;9:105–108
   PubMed Web of Science ®Google Scholar
• Nakagawa H, Murata Y, Koyama K, Fujiyama A, Miyoshi Y, Monden M, et al. Identification of a brain-specific APC homologue, APCL, and its interaction with β-catenin. Cancer Res 1998;58:5176–5181
   PubMedGoogle Scholar
• Naghibalhossaini F, Hosseini HM, Mokarram P, Zamani M. High frequency of genes' promoter methylation, but lack of BRAF V600E mutation among Iranian colorectal cancer patients. PatholOncol Res 2011;17:819–825
   PubMed Web of Science ®Google Scholar
• Rahmatpanah FB, Carstens S, Hooshmand SI, Welsh EC, Sjahputera O, Taylor KH, et al. Large scale analysis of DNA methylation in chronic lymphocytic leukemia. Epigenomics 2009;1:39–61
   PubMed Web of Science ®Google Scholar
• Nakagawa H, Koyama K, Murata Y, Morito M, Akiyama T, Nakamura Y. EB3, a novel member of the EB1 family preferentially expressed in the central nervous system, binds to a CNS-specific APC homologue. Oncogene 2000;19:210–216
   Google Scholar
• McCartney BM, McEwen DG, Grevengoed E, Maddox P, Bejsovec A, Peifer M. Drosophila APC2 and Armadillo participate in tethering mitotic spindles to cortical actin. Nat Cell Biol 2001;3:933–938
   PubMed Web of Science ®Google Scholar
• Yamanaka H, Hashimoto N, Koyama K, Nakagawa H, Nakamura Y, Noguchi K. Expression of Apc2 during mouse development. Brain Res Gene Expr Patterns 2002;1:107–114
   Google Scholar
• Shintani T, Ihara M, Tani S, Sakuraba J, Sakuta H, Noda M. APC2 plays an essential role in axonal projections through the regulation of microtubule stability. J Neurosci 2009;29:11628–11640
   Google Scholar
• Mohan A, Nalini V, Mallikarjuna K, Jyotirmay B, Krishnakumar S. Expression of motility-related protein MRP1/CD9, N-cadherin, E-cadherin, alpha-catenin and beta-catenin in retinoblastoma. Exp Eye Res 2007;84:781–789
   PubMedGoogle Scholar
• Mitra M, Harilal A, Verma RS, Krishnan UM, Swaminathan S, Kumar KS. EpCAM is a putative stem marker in retinoblastoma and an effective target for T-cell-mediated immunotherapy. Mol Vis 2012;18:290–308
   PubMed Web of Science ®Google Scholar
• Ganguly A, Shields CL. Differential gene expression profile of retinoblastoma compared to normal retina. Mol Vis 2010;16:1292–1303
   PubMed Web of Science ®Google Scholar
• Mallikarjuna K, Sundaram CS, Sharma Y, Deepa PR, Khetan V, Gopal L, et al. Comparative proteomic analysis of differentially expressed proteins in primary retinoblastoma tumors. Proteomics Clin Appl 2010;4:449–463
   PubMed Web of Science ®Google Scholar
• Sudhakar J, Venkatesan N, Lakshmanan S, Khetan V, Krishnakumar S, Biswas J. Hypoxic tumor micro environment in advanced retinoblastoma. Pediatr Blood Cancer 2013;60:1598–1601
   PubMed Web of Science ®Google Scholar
• Kumar K, Brim, H, Giardiello F, Smoot DT, Nouraie M, Lee EL, et al. Distinct BRAF (V600E) and KRAS mutations in high microsatellite instability sporadic colorectal cancer in African Americans. Clin Cancer Res 2009;15:1155–1161
   Google Scholar
• Nguyen C, Liang G, Nguyen TT, Tsao-Wei D, Groshen S, Lubbert M, et al. Susceptibility of nonpromoter CpG islands to de novo methylation in normal and neoplastic cells. J Natl Cancer Inst 2001;93:1465–1472
   PubMed Web of Science ®Google Scholar
• Choai JK. Contrasting chromatin organization of CpG islands and exons in the human genome. Genome Biol 2010;11:R70
   Google Scholar
• Kempster S, Phillips WA, Baindur-Hudson S, Thomas RJ, Dow C, Rockman SP. Methylation of exon 2 of p16 is associated with late stage oesophageal cancer. Cancer Lett 2000;150:57–62
   PubMed Web of Science ®Google Scholar
• Lubin FD, Roth TL, Sweatt JD. Epigenetic regulation of BDNF gene transcription in the consolidation of fear memory. Neurosci 2008;28:10576–10586
   Google Scholar
• Fang JY, Chen YX, Lu J, Lu R, Yang L, Zhu HY, et al. Epigenetic modification regulates both expression of tumor-associated genes and cell cycle progressing in human colon cancer cell lines: Colo-320 and SW1116. Cell Res 2004;14:217–222
   PubMed Web of Science ®Google Scholar
• Shen WJ, Dai DQ, Teng Y, Liu HB. Regulation of demethylation and re-expression of RASSF1A gene in gastric cancer cell lines by combined treatment of 5-Aza-CdR and NaB. World J Gastroenterol 2008;14:595–600
   Google Scholar